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Summary
The regulation of protein synthesis is vital for a host
of cell biological processes, but investigating roles
for protein synthesis have been hindered by the in-
ability to selectively interfere with it. To inhibit protein
synthesis with spatial and temporal control, we have
developed a photo-releasable anisomycin compound,
N-([6-bromo-7-hydroxycoumarin-4-yl]methyloxycar-
bonyl)anisomycin (Bhc-Aniso), that can be removed
through exposure to UV light. The area of protein
synthesis inhibition can be restricted to a small light-
exposed region or, potentially, the volume of two-pho-
ton excitation if a pulsed IR laser is the light source.
We have tested the compound’s effectiveness with an
in vitro protein-translation system, CHO cells, HEK293
cells, and neurons. The photo-released anisomycin
can inhibit protein synthesis in a spatially restricted
manner, which will enable the specific inhibition of
protein synthesis in subsets of cells with temporal and
spatial precision.
Introduction
Delivering biological effectors to cell and tissue culture
samples with temporal and spatial precision is useful
for elucidating complex physiological processes. One
method for regulating the action of biological effectors
utilizes a photolabile-protecting group to render a bio-
logical effector inactive (“caged”) until it is exposed to
a flash of UV light. This cleaves away the protecting
group (“uncaging”), resulting in a rapid increase in the
effector concentration. A number of photolabile-pro-
tecting or “caging” groups have been developed for
this purpose [1–4], including p-nitrobenzyl (p-NB), 4,5-
dimethoxy-2-nitrobenzyl (DMNB), and 6-bromo-7-hydro-
xycoumarin-4-ylmethyl (Bhc) [5], the latter of which is
especially useful for controlling the three-dimensional
spatial release of biological effectors because of its
sensitivity to two-photon excitation [6–11]. Many caged
activators of biological function, such as neurotrans-
mitters and second messengers, have been generated*Correspondence: schumane@caltech.edu (E.M.S.); tdore@chem.
uga.edu (T.M.D.)
3 These authors contributed equally to this work.and effectively utilized to study signal transduction, but
there are few examples in which a caged antagonist
has been used to inhibit a biological process with light
[12–18].
The targeting of mRNA and local synthesis of pro-
teins in polarized cells provides specificity to such di-
verse cell functions as fate specification, body plan for-
mation, axon guidance, and synaptic plasticity. For
example, in Drosophila the local synthesis of proteins
such as oskar [19] or bicoid [20, 21] sets up the initial
patterning of the embryo. In neurons, it is likely that
local synthesis of proteins in dendrites and axons con-
tribute some of the proteins required for axon outgrowth
[22–24] and synaptic plasticity [25–28]. A method for reg-
ulating the local inhibition of protein synthesis is de-
sired to better understand the role of local protein syn-
thesis in these and other systems. This paper describes
a method for the spatially restricted inhibition of protein
synthesis in mammalian cells and neurons with a caged
version of the protein-synthesis inhibitor anisomycin,
which blocks the peptide-bond-forming reaction in
eukaryotic ribosomes [29, 30].
Results
The caged anisomycins, p-NB-Aniso (3a), DMNB-Aniso
(3b), and Bhc-Aniso (3c) were synthesized by treating
anisomycin with the respective chloroformate of the
caging group (Figure 1). The one- and two-photon pho-
tolysis properties of each compound were evaluated in
order to determine which of the three caged anisomy-
cins is best suited for regulating protein synthesis in
neurons. When p-NB-Aniso, DMNB-Aniso, and Bhc-
Aniso are irradiated with 365 nm light (Figure 1), the
reaction progress curves fit to a simple decaying expo-
nential (Figure 2A) with time constants (τ) of 22,173,
187, and 20.9 s, respectively, which correspond to un-
caging quantum efficiencies (Qu) of 0.00007, 0.012, and
0.040 mol/ein, respectively. The maximum measured
concentration of anisomycin was reached after 100 s
of irradiation of Bhc-Aniso. Thus, Bhc-Aniso possesses
superior uncaging kinetics when compared to the other
compounds, and with an uncaging action cross-section
(du) of 0.59 GM, it has sufficient sensitivity to two-pho-
ton excitation for biological use (Figure 2B) [5, 11].
Spectroscopic and photochemical (1- and 2-photon)
data for the caged anisomycins are summarized in Ta-
ble 1. All of the caged anisomycin compounds were
stable in the dark and behaved similarly under simu-
lated physiological conditions: 98.1% of p-NB-Aniso,
97.8% of DMNB-Aniso, and 96.5% of Bhc-Aniso re-
mained after 19 hr at 24°C and pH 7.2 (data not shown).
LC/MS monitoring of the dark hydrolysis of Bhc-Aniso
revealed that the disappearance of substrate is not a
result of hydrolysis of the carbamate linkage but, rather,
the loss of the acetate at C3 of anisomycin. No prod-
ucts resulting from carbamate hydrolysis were ob-
served during the time course of the experiment (190 hr).
The ability of the caged anisomycin compounds to
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686Figure 1. Synthesis and Photochemical Re-
action of Caged Anisomycins
Reagents and conditions: (a) Na2CO3, THF,
room temperature (rt), 2 hr, 58%; (b) Na2CO3,
THF, rt, 2 hr, 67%; (c) Na2CO3, H2O, THF, rt,
1 hr, 35%; (d) hν (365 or 740 nm), KMOPS
buffer (pH 7.2).wfor 0.5–10 s. After UV exposure, the compounds were
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Figure 2. Photolytic Characterization of Caged Anisomycins
t
(A) Typical one-photon photolysis kinetics of caged anisomycin at
(365 nm. Bhc-Aniso (■) was photolyzed to produce anisomycin (,);
Aτ, 20.9 s; R2, 0.998. DMNB-Anisomycin (C) was also photolyzed to
Aproduce anisomycin (B); τ, 187 s; R2, 1.000. p-NB-Aniso (%) did
not produce any measurable amount of anisomycin during the time t
course of photolysis; τ, 22,173 s; R2, 0.890. t
(B) Time course of two-photon photolysis of DMNB- and Bhc-An- c
iso. Bhc-Aniso (■) was photolyzed with a mode-locked and fs- r
pulsed Ti:sapphire laser (740 nm) to produce anisomycin (,); τ,
e89.3 min; R2, 0.996. DMNB-Aniso (,) was similarly photolyzed to
fproduce anisomycin (B); τ, 917 min, R2, 0.943. Error bars represent
the standard deviation from at least three measurements. Ginhibit protein synthesis was then assessed with an in a
tvitro translation assay. Bhc- and DMNB-caged aniso-
mycins were activated by exposure to 280–390 nm light tdded to in vitro translation reactions at a final concen-
ration of 40 M (Figures 3A and 3B). The potency of
he uncaged compounds in inhibiting protein synthesis
as compared to unmodified anisomycin (40 M).
MNB-Aniso demonstrated a significant inhibition of
rotein synthesis after 10 s of UV exposure but little
nhibition after 2 s of exposure (Figure 3A, lanes 1 and
). The Bhc-Aniso was able to completely inhibit protein
ynthesis after as little as 2 s of exposure (Figure 3A,
anes 2 and 4). Both Bhc- and DMNB-Aniso com-
ounds were stable and showed no inhibition of syn-
hesis after 45 min of exposure to ambient light when
ompared to the vehicle control (Figure 3A, lanes 6–8).
ecause Bhc-Aniso possessed equal stability and
reater uncaging efficiency than the DMNB-Aniso, it
as chosen as the compound to use for the local in-
ibition experiments. Further characterization of the
hc-Aniso, carried out with irradiation at 365 ± 10 nm,
ndicated that complete inhibition of protein synthesis
ould be achieved after 1.4 s of exposure or less (Figure
B). Note that p-NB-Aniso was also able to inhibit pro-
ein synthesis after UV exposure, but the required time
f exposure, 5 min, and concentration, 400 M, were
rohibitively high (data not shown).
We determined the effects of UV light on cell viability
n order to ascertain tolerable levels of UV exposure.
o accomplish this, we exposed cultured hippocampal
eurons to UV light of variable duration and then con-
ucted propidium iodide labeling. We found that neu-
ons tolerated a continuous UV-light exposure of up to
min (Figures 3C and 3D). Exposure times of 2.5 min
r greater led to significant neuronal death; thus, in
ubsequent experiments, the total UV exposure experi-
nced by cells was always less than 1 min.
To visualize protein-synthesis inhibition dynamically
n intact cells, we used a GFP reporter [31] and moni-
ored fluorescence levels in Chinese hamster ovary
CHO) cells before and after local uncaging of Bhc-
niso. In regions of a culture dish in which the Bhc-
niso was uncaged by two 500-ms pulses (500-ms in-
erpulse interval) of w365 nm light every ten minutes,
here was a significant reduction in cellular fluores-
ence over the course of 2 hr (Figures 4A and 4D). In
egions of the same dish in which there was no UV-light
xposure (and, therefore, no uncaged Bhc-Aniso), the
luorescence levels of cells increased because of new
FP synthesis (Figures 4A and 4D). Thus, we were able
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687Table 1. Summary of Spectroscopic and Photolytic Characteristics of Caged Anisomycins
Compound lmax (nm) e (M−1 cm−1) Qu (mol/ein)a du (GM)b
p-NB-Aniso (3a) 274 9,400 0.007 ± 0.003 × 10−2 —
DMNB-Aniso (3b) 350 6,200 1.2 ± 0.1 × 10−2 0.048 ± 0.003
Bhc-Aniso (3c) 373 14,500 4.0 ± 0.4 × 10−2 0.59 ± 0.05
a One-photon quantum efficiency for uncaging at 365 nm. Uncertainty is the standard deviation from at least three experiments.
b Two-photon uncaging action cross-section at 740 nm (GM, 10−50 cm4 s/photon). Uncertainty is the standard deviation from at least three
experiments.sure did not alter the low background levels of cellthe dendrites over the 3 hr during which images were
Figure 3. Assessment of the Uncaging Effi-
ciency of Bhc-Aniso and DMNB-Aniso with
In Vitro Assays and Characterizing UV Toler-
ance in Neurons with Propidium Iodide Ex-
clusion Assay
(A and B) Caged anisomycins exposed to
various amounts of UV, unmodified aniso-
mycin, caged anisomycin exposed to ambi-
ent light, fresh caged anisomycin, and vehicle
(DMSO) were added to an in vitro translation
reaction. After 1 hr, the [35S]-methionine in-
corporation of these reactions was analyzed
by SDS-PAGE. This assay was used to
compare the relative caging efficiencies of
DMNB-Aniso and Bhc-Aniso (A) and to char-
acterize the timescale of Bhc-Aniso uncag-
ing with 365 nm light exposure (B).
(C) Cultured neurons exposed to uninter-
rupted UV for 0, 1, 2.5, or 5 min followed by PI treatment. Scale bar, 50 m.
(D) Bar graph showing propidium iodide (PI)-particle count normalized to 0 min exposure controls. N (dishes), 5 for all groups. Error bars
represent the standard error of the measurement.to locally inhibit synthesis in cells in one region of the
culture dish while maintaining uninterrupted protein
synthesis in other cells in the same dish.
There is a concern that UV exposure itself may
bleach the GFP signal and thereby simulate the pre-
dicted effects of protein synthesis inhibition in the cells.
We found that this was not the case with our UV-expo-
sure protocol. Cells expressing GFP and exposed to UV
(in the absence of Bhc-Aniso) showed a steady in-
crease in GFP fluorescence that was statistically indis-
tinguishable from the increases in fluorescence demon-
strated by unexposed controls (Figures 4B and 4D).
Compromised cell health was another concern be-
cause UV exposure or any free radicals generated in
the uncaging process could damage the cells. We as-
sessed by morphological examination and propidium
iodide (PI) staining of the UV-exposed cells. The cells
expressing the reporter and exposed to UV irradiation
did not exhibit any obvious morphological abnormali-
ties or sequester PI, indicating that cell health was not
compromised by our uncaging protocol (Figures 4C
and 4D).
We next examined the ability of Bhc-Aniso to inhibit
protein synthesis in neurons expressing the GFP repor-
ter. We positioned a fiber optic light source in order to
uncage Bhc-Aniso in the neuron (Figure 5A). We then
monitored GFP fluorescence levels in the dendrites of
control neurons and neurons exposed to the uncaging
protocol. In control neurons (Bhc-Aniso was applied in
the bath but no UV light was administered; “caged”),
there was an increase in GFP fluorescence observed inacquired (Figures 5B and 5D). In contrast, neurons ex-
posed to UV light in the presence of Bhc-Aniso did
not exhibit an increase in dendritic fluorescence but
showed a small decrease in fluorescence over time
(Figures 5C and 5D). In control experiments, neurons
exposed to UV light in the absence of Bhc-Aniso
(“flash”) or neurons exposed to DMSO vehicle exhibited
increases in dendritic protein synthesis comparable to
those exposed to Bhc-Aniso without UV exposure (Fig-
ure 5D). The inhibition of protein synthesis induced by
uncaging was indistinguishable from that observed in
neurons that were treated with anisomycin (40 M) (Fig-
ure 5D). This indicates that our uncaging protocol inhib-
its protein synthesis with the same efficacy as bath ap-
plication of an unmodified protein-synthesis inhibitor.
We next addressed the spatial specificity of our un-
caging protocol by examining the degree of protein-
synthesis inhibition as a function of distance from the
uncaged region. Time-lapse imaging of HEK293 cells
expressing a GFP reporter were obtained before and
during uncaging of Bhc-Aniso. We analyzed the change
in fluorescence in cells at increasing distances from the
uncaging spot. Cells in the center of the spot exhibited
maximal decreases in fluorescence levels that were evi-
dent 60 min after the onset of uncaging and persisted
for at least 3 hr (Figure 6). These decreases were maxi-
mal within 100 m from the center of the uncaging spot
(Figure 6C). In contrast, cells outside the uncaging spot
showed constant or, in some cases, increasing levels
of fluorescence during the experiment (Figure 6C). Pro-
pidium iodide exclusion assays indicated that UV expo-
Chemistry & Biology
688Figure 4. Inhibition of Protein Synthesis in CHO Cells Transfected with GFP Reporter
(A) Uncaging of Bhc-Aniso inhibits GFP synthesis. The top panels show a representative cell that was treated with Bhc-Aniso uncaged by UV
exposure (mean fluorescence intensity decreased by 15.8% at 60 min and 42.8% at 120 min). The bottom panels show a cell from the same
dish that was treated to Bhc-Anisomycin but had no UV exposure (3.2% increase at 60 min and 20.0% increase at 120 min).
(B) UV exposure alone does not inhibit GFP synthesis. The top panels show a representative cell that was treated with vehicle and UV
exposure (12.9% increase at 60 min and 23.4% increase at 120 min). The bottom panels show a cell from the same dish that was outside the
UV-exposed region (9.2% at 60 min and 14.3% at 120 min). Scale bar, 10 m.
(C) Protein synthesis can be locally inhibited by the spatially restricted uncaging of Bhc-Aniso. The leftmost panel shows the relative positions
of the UV-exposed (“uncaged”; top) and -unexposed (“caged”; bottom) cells (scale bar, 50 m). The middle panels show the two cells at 0
and 60 min (24.7% decrease at 60 min for “uncaged” cell, 11.3% increase at 60 min for “caged” cell); scale bar, 10 m. The right panels
show propidium iodide exclusion by each cell at the conclusion of the experiment (green, GFP; red, propidium iodide; scale bar, 50 m).
Lookup table shows scale of fluorescence from no signal (black) to saturated (white).
(D) Summary data for local inhibition experiments in CHO cells. Cells incubated in Bhc-Aniso and exposed to UV (uncaged) displayed a
significant decrease over time when compared to cells exposed to Bhc-Aniso without UV (caged), UV alone (exposed), and untreated controls
(unexposed) (p < 0.01 for all controls at 60 and 120 min). The caged, exposed, and unexposed groups were not statistically different from
each other. N (cells) for each group are as follows: uncaged (6); caged (10); exposed (6); and unexposed (6). Error bars represent the standard
error of the measurement.death observed in HEK293 cells. These experiments in- a
tdicate that spatially restricted inhibition of the GFP re-
porter synthesis can be achieved. p
m
lDiscussion
v
aWe have described a method for the light-controlled
minhibition of protein synthesis with a caged protein-syn-
cthesis inhibitor, Bhc-Aniso. We have shown that we can
psignificantly inhibit protein synthesis in cells in one re-
tgion of a culture dish while allowing protein production
to go unhindered in other cells (w200–500 m away)
in the same dish. Additionally, this spatially restricted S
inhibition of protein synthesis had no visible detrimen-
tal effect on cell health over the time frame of our ex- I
bperiments (2 hr). Bhc-Aniso is stable in the presence ofmbient light, and it is efficiently photolyzed. The pho-
ochemical studies on Bhc-Aniso, DMNB-Aniso, and
-NB-Aniso show that the Bhc-caged anisomycin is far
ore sensitive to single- and two-photon-mediated re-
ease of the drug than the DMNB- or the p-NB-caged
ersions. Significant amounts of anisomycin are liber-
ted from Bhc with limited UV exposure, thereby mini-
izing any toxic effects to cells. Its rapid rate of un-
aging may also enable high temporal precision of
rotein-synthesis inhibition because a high concentra-
ion of anisomycin can be rapidly generated.
ignificance
t is now possible to inhibit protein synthesis with
oth spatial and temporal precision. We have demon-
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689Figure 5. Inhibition of Protein Synthesis in Neurons
(A) Experimental setup for whole-neuron uncaging of Bhc-Aniso. A hippocampal neuron transfected with 5#myrdGFP3# protein synthesis
reporter is shown with 400-m diameter optic fiber positioned to deliver UV light to the neuron.
(B) A representative transfected neuron treated with Bhc-Aniso outside the UV-exposed region (“caged”) at 0 (left) to 180 min (middle).
Straightened dendrites (bottom) are shown at 0 and 180 min (dendrite length, 250 m), with the change in fluorescence quantified by a F/F
plot (right). Lookup table ranges from no signal (black) to saturated signal (white); scale bar, 25 m.
(C) A representative neuron from the same dish inside the UV-exposed region (“uncaged”) at 0 (left) to 180 min (middle). Straightened dendrites
(bottom) are shown at 0 and 180 min (dendrite length, 250 m), with the change in fluorescence quantified by a F/F plot (right). Lookup
table ranges from no signal (black) to saturated signal (white); scale bar, 25 m.
(D) Neurons treated with Bhc-Aniso and flashed with UV (uncaged) did not increase in fluorescence, similar to cells treated with anisomycin
(Aniso). Both of these groups were significantly different (p < 0.05) from the three controls: cells treated with Bhc-Aniso but not UV (caged),
cells treated with UV in the presence of vehicle (flash), and cells treated only with vehicle (DMSO). The three controls were statistically
indistinguishable form each other. N (cells) for each group as follows: uncaged (8); caged (7); flash (6); aniso (9); and DMSO (8). Error bars
represent the standard error of the measurement.
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690Figure 6. Protein-Synthesis Inhibition Is Spatially Restricted
(A and B) Representative field of HEK293 cells transfected with GFP protein-synthesis reporter at 0 and 180 min. Red oval shows region of
UV exposure delivered by 400-m optic fiber; yellow squares show representative areas inside and outside of the UV-exposure region
magnified in (B). Lookup table ranges from no signal (black) to saturated signal (white); scale bar, 250 m. (B) Magnified regions from (A)
inside and outside of the UV-exposure region at 0 and 180 min; scale bar, 50 m.
(C) Plots showing normalized change in fluorescence versus distance from the center of the UV-exposure region at 60, 120, and 180 min for
Bhc-Anisomycin-treated cells (white) and vehicle-treated cells (red). Error bars represent the standard error of the measurement.strated spatially restricted inhibition with a simple t
asystem available to most biological investigators: a
fiber optic delivery system with a 100 W mercury arc- i
nlamp light source. These experiments demonstrate
that it is feasible to maintain a high concentration U
iof an inhibitor in a restricted region for prolonged
periods, opening the door for other compounds to be s
cused in a similar fashion. Nevertheless, the use of
more sophisticated light-delivery systems offers the
possibility of greater spatial control in more complex E
systems. Fiber optics can be used to deliver light with
a higher spatial specificity than can typically be S
Aachieved with a standard microscope objective [32,
g33]. Spot sizes of UV illumination as small as 10 m
Mcan be generated by controlling the fiber tip size or
aby using mirrored micropipettes with small apertures.
wBy using these small spot sizes to activate the caged p
synthesis inhibitor, one could precisely restrict syn- V
ithesis in structures as small as a dendritic spine. Fur-her spatial regulation of inhibitor action could be
chieved if one exploited the large two-photon uncag-
ng action cross-section of Bhc-Aniso, obviating the
eed to insert a fiber or micropipette into tissue [8–11].
sing this technique would also avoid possible toxic-
ty from long-term UV exposure to cells. This repre-
ents a novel method of delivering drugs to biologi-
al systems.
xperimental Procedures
ynthesis of Caged Anisomycins
nisomycin was purchased from AG Scientific and Sigma. Phos-
ene was purchased from Fluka as a 20% solution in toluene (1.93
). 6-Bromo-7-hydroxy-4-hydroxymethyl-coumarin was prepared
ccording to published procedure [5]. Other reagents and solvents
ere purchased from Aldrich or Fisher and used without further
urification. 1H NMR and 13C NMR spectra were recorded on a
arian Mercury 300 MHz, INOVA 500 MHz, or MercuryPlus 400 MHz
nstrument, as noted. FTIR spectra were recorded on a Bruker Vec-
Light-Mediated Inhibition of Protein Synthesis
691tor 22 spectrophotometer. UV spectra were recorded on a Cary 300
Bio UV-Visible spectrophotometer (Varian). ESI MS and LC/MS
were determined on a Sciex API-1 quadrupole mass spectrometer
with an electrospray ionization source. HPLC analysis (analytical
and preparative) was performed on a Varian ProStar HPLC system
with an autosampler and diode array detector with Microsorb C-18
reverse-phase columns. KMOPS buffer consisted of 100 mM KCl
and 10 mM MOPS titrated to pH 7.2 with KOH. Thin-layer and col-
umn chromatography were performed on precoated silica gel 60
F254 plates (EM Science) and 230–400 mesh silica gel 60 (EM Sci-
ence), respectively.
N-(4-Nitrobenzyloxycarbonyl)anisomycin (p-NB-Aniso, 3a)
Anisomycin (1, 90.2 mg, 0.34 mmol), 4-nitrobenzylchloroformate
(2a, 75.3 mg, 0.34 mmol), and sodium carbonate (40.7 mg, 0.38
mmol) were stirred in anhydrous THF (4 ml) for 2 hr. The reaction
was filtered, and the solvent was removed by rotary evaporation,
leaving a yellow oil, which was purified over silica gel with ethyl
acetate/toluene (1:1) to yield 87.0 mg (0.197 mmol, 58%) of product
3a. 1H NMR (300 MHz, CDCl3, δ): 7.71 (s, 1H), 7.2–7.0 (m, 3H), 6.77
(d, 2H), 5.52 (m, 2H), 4.88 (m, 1H), 4.46 (m, 1H), 4.02 (m, 1H), 3.95
(s, 6H), 3.76 (s, 3H), 3.6–3.5 (m, 2H), 3.22 (d, 1H), 2.9–2.8 (m, 1H),
2.60 (m, 1H), 2.11 (s, 3H); 13C NMR (75 MHz, CDCl3, δ): 170.8, 158.4,
154.9, 153.6, 148.3, 140.2, 130.4, 129.8, 128.2, 127.6, 114.0, 110.3,
79.1, 78.5, 72.4, 71.8, 64.3, 60.2, 56.6, 55.4, 51.7, 32.9, 21.1; ESI
MS, m/z: [M + Cl]− 479.
N-(4,5-Dimethoxy-2-nitrobenzyloxycarbonyl)anisomycin
(DMNB-Aniso, 3b)
Prepared in 67% yield as described for 3a but with chloroformate
2b. 1H NMR (500 MHz, CDCl3, δ): 8.19 (s, 2H), 7.46 (d, 2H), 7.00 (d,
2H), 6.75 (s, 2H), 5.20 (m, 2H), 4.88 (m, 1H), 4.44 (br s, 1H), 4.12–
4.04 (m, 1H), 3.74 (s, 3H), 3.58–3.49 (m, 2H), 3.19 (m, 2H), 2.81 (m,
1H), 2.09 (s, 3H); 13C NMR (125 MHz, CDCl3, δ): 170.8, 158.4, 154.8,
147.7, 144.2, 130.3, 129.8, 128.4, 123.9, 114.0, 79.1, 72.2, 66.0, 60.0,
55.3, 51.7, 29.8, 21.0; ESI MS (m/z): [M + Na]+ 527.2.
N-([6-Bromo-7-hydroxycoumarin-4-
yl]methyloxycarbonyl)anisomycin (Bhc-Aniso, 3c)
Adapted from Iino et al. [34]. Chloroformate 2c was prepared by
adding a 20% phosgene solution (1.26 ml, 2.22 mmol) via syringe
to a solution of 6-bromo-7-hydroxy-4-hydroxymethylcoumarin (100
mg, 0.37 mmol) in dry THF (4 ml) under nitrogen. The solution was
stirred for 1 hr and then purged with nitrogen to concentrate it to
approximately half the original volume. In a separate reaction ves-
sel, an aqueous solution of 1.0 M sodium carbonate (0.34 ml) was
added to a solution of anisomycin (42 mg, 0.16 mmol) in THF (1
ml). The solution of chloroformate 2c was added dropwise over 10
min to this mixture while stirring and cooling on ice. The reaction
mixture was stirred at room temperature for 1 hr. After addition of
another solution of chloroformate 2c prepared as described above,
the mixture was stirred for 2 hr. The reaction was quenched with
15% citric acid, diluted with chloroform, and extracted with water.
The organic layer was dried (MgSO4) and evaporated to a residue
on the flask wall. The crude product was purified by flash-column
chromatography (ethyl acetate/hexane 6:4) to yield 31 mg (0.055
mmol, 35%) of product. 1H NMR (400 MHz, CDCl3, 1.8:1 mixture of
conformational isomers, δ): 7.65 and 7.62 (s, 1H), 7.09 and 7.02 (d,
2H), 6.93 (s, 1H), 6.81 (m, 2H), 6.32 and 6.20 (s, 1H), 5.28 (AB q, 2H),
4.96 (m, 1H), 4.48 (br m, 1H), 4.12 and 4.06 (br s, 1H), 3.78 and 3.74
(s, 3H), 3.60 (m, 2H), 3.30 and 2.98 (d, 1H), 2.85 (m, 1H), 2.14 (s, 3H),
2.00 (br, 2H); 1H NMR (400 MHz, DMSO-d6, 88°C, δ): 7.89 (s, 1H),
7.03 (d, J = 8.2 Hz, 2H), 6.92 (s, 1H), 6.79 (d, J = 8.2 Hz, 2H), 6.19
(s, 1H), 5.30 (AB q, 2H) 4.79 (dd, J = 5.1, 10.2 Hz, 1H), 4.28 (m, 1H),
3.95 (dd, J = 4.3, 8.6 Hz, 1H), 3.70 (s, 3H), 3.60 (br, 2H), 3.48 (dd,
J = 5.1, 11.3 Hz, 1H), 3.39 (dd, J = 3.1, 10.9 Hz, 1H), 3.50 (br, 1H),
2.75 (dd, J = 9.0, 13.7, 1H), 2.04 (s, 3H); 13C NMR (100 MHz, DMSO-
d6, mixture of conformational isomers, δ): 169.5, 159.6, 157.6,
157.4, 154.0, 153.8, 150.7, 150.1, 129.8, 129.6, 129.5, 128.6, 128.4,
113.6, 110.5, 110.4, 109.5, 108.3, 106.2, 103.1, 77.2, 76.4, 70.1, 69.8,
62.2, 61.6, 59.6, 59.0, 54.8, 51.9, 33.2, 31.8, 20.6; FTIR (neat) 3430,
3188, 3016, 2930, 1750, 1719, 1703, 1688, 1602, 1422, 1219, 656
cm−1; ESI MS (m/z): MH+ 562, 564. Samples for characterization,photochemical analysis, and biological studies were further puri-
fied by preparative HPLC (50% CH3CN and 50% H2O containing
0.1% trifluoroacetic acid).
Measurements of Quantum Efficiencies
Quantum efficiencies, Qu, were determined in KMOPS-buffered so-
lutions (3 ml) of the caged anisomycins (100 M) as previously de-
scribed [5, 35–38]. Briefly, samples were irradiated with 365 nm
light from a mercury lamp (Spectroline SB-100P; Spectronics Cor-
poration, Westbury, NY). The spectral output of the lamp is a distri-
bution across the UV-A wavelengths (310–400 nm) with an intense
band at 365 nm. After a period of irradiation, a 20 l aliquot of the
solution was removed for analysis by HPLC with an isocratic mix-
ture of 50% acetonitrile and 50% water containing 0.1% trifluoro-
acetic acid (flow rate of 1 ml/min). Absorbance was detected at 325
nm (Bhc-Aniso), 345 nm (DMNB-Aniso), 270 nm (p-NB-Aniso), and
225 nm (Anisomycin). The progress curves were plotted as simple
decaying exponentials. Quantum efficiencies were calculated with
Qu = (Ist90%)−1, in which I is the irradiation intensity in ein , cm−2 ,
s−1, s is the decadic extinction coefficient (103 × e, the molar extinc-
tion coefficient) in cm2 , mol−1, and t90% is the irradiation time in
seconds for 90% conversion to product. The UV intensity of the
lamp I was measured by using potassium ferrioxalate actinometry
[39] in the same setup.
Determination of Dark Hydrolysis Rates of Caged Anisomycins
Substrates were placed into a KMOPS-buffered solution and stored
in the dark at room temperature. HPLC analysis was carried out
periodically as described for the quantum efficiency measure-
ments. The identity of the hydrolysis products was determined by
LC/MS.
Measurement of Two-Photon Uncaging Cross-Sections
Cross-sections, du, of DMNB-Aniso and Bhc-Aniso were measured
as previously described with the HPLC conditions described for
the quantum efficiency measurements [5, 37, 38].
In Vitro Translation Experiments
A given caged anisomycin compound (4 mM in DMSO) was ex-
posed to 280–390 nm or 365 ± 10 nm light (filters from Chroma
Technology, Corp., Brattleboro, VT) for the given amount of time.
The UV exposure was delivered through a 20× objective (N.A. 0.46)
on an Olympus Provis AX 70 microscope with a 100 W mercury arc
lamp as the light source. After exposure, the caged compound (or
an anisomycin or a vehicle control) was added at a final concentra-
tion of 40 M to an in vitro translation reaction (Promega, Madison,
WI) with [35S]-methionine incorporation to detect protein synthesis.
The level of incorporation after incubation with the inhibitor or con-
trol was assessed by SDS-PAGE.
Local Inhibition Experiments in CHO Cells
CHO cells were maintained and propagated under standard condi-
tions (5% CO2 in Ham’s F12 medium containing 10% fetal bovine
serum). Prior to transfection, cells were grown in 35 mm culture
dishes or 6-well plates at 95% confluence. Cells were transfected
by utilizing Lipofectamine 2000 (Invitrogen, Carlsbad, CA) with a
GFP reporter plasmid (pEGFP-C1 [Clontech, Palo Alto, CA]) as de-
scribed by the protocol provided by Invitrogen.
After 5 hr of transfection, CHO cell growth media was replaced
with a HEPES-buffered solution (HBS) [40] (without glycine or pic-
rotoxin) with 2 mM ascorbic acid and 40 M Bhc-Anisomycin (or
vehicle control). Cells were incubated in this media for 1 hr at room
temperature. After incubation, transfected cells were imaged, and
one cell (or set of cells) was exposed to 365 ± 10 nm light (Oriel,
Stratford, CT) twice for 0.5 s (with a 0.5 s interpulse interval) every
10 min. The UV exposure was delivered through a 40× objective
(N.A. 0.80) on an Olympus Provis AX 70 microscope with a 100 W
mercury arc lamp as the light source. Subsequent fluorescent
images were taken every hour. GFP was excited with a 100 W mer-
cury arc lamp. Single images were taken by using a Hamamatsu
digital camera with a 1.5× zoom; excitation filter, 480 ± 40 nm;
emission filter, 535 ± 50 nm (Chroma). The exposure time for the
images varied depending on the original fluorescence level of the
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692cells but was kept constant for each dish (both experimental and p
acontrol cells) throughout the experiment. Cell health was assessed
after each local inhibition experiment in CHO cells by propidium 4
aiodide (PI) exclusion. Cells were incubated in PI solution (50 g/ml)
for 5 min and then washed with HBS. They were subsequently im- (
taged in HBS to assess cell health. The change in GFP fluorescence
was quantified by expressing the percentage change in total mean e
mpixel intensity from the 0-min time point to the 60-min or 120-min
time point (ImageJ). For comparison of conditions, a one-way r
bANOVA was performed with the LSD post-hoc test (α = 0.05).
p
tLocal Inhibition Experiments in Neurons
tDissociated hippocampal neuron cultures were prepared from
lpostnatal 2- and 3-day rat pups as described [41]. Neurons were
tplated at a density of 15,000–45,000 cells/cm2 onto poly-L-lysine-
scoated cell-culture dishes (MatTek). The cultures were maintained
tand allowed to mature in growth medium (Neurobasal-A supple-
(mented with B27 and Gluta MAX-1) for 14–21 days before use. Dis-
sociated hippocampal neurons were incubated for 30 min in growth
Cmedium with the Sindbis virus (construction and production of
CSindbis virus containing the 5#myrdGFP3# reporter has been pre-
wviously described) [31], washed with a HEPES-buffered solution
t(HBS), and placed back in clean growth medium. After the incuba-
ttion, the growth medium was removed and replaced with HBS con-
qtaining 5 mM ascorbic acid (pH 7.4) and either caged anisomycin
i(80 M), standard anisomycin (40 M), or DMSO (0.05%). Bhc-
sAniso (80 M) was used so that after the loss of product because
eof uncaging, the total uncaged anisomycin would be approximately
e40 M and, thus, comparable to the standard anisomycin used in
controls (see Figure 1B). The cells were incubated for 1 hr in this
Amedium at room temperature. The dish was then imaged by confo-
cal microscopy (see below), and one cell (or set of cells) was ex-
Tposed to 360 ± 10 nm light (Oriel) for 45 ms every 11 s (0.095 Hz)
tfor 3 hr, with a total exposure time of 44.2 s for the entire experi-
vment. Flash duration was controlled with a Uniblitz shutter driver
s(Vincent Associates, Rochester, NY), and the UV exposure was de-
Wlivered through a 400-m optic fiber (Rapp OptoElectronic, Ham-
Tburg, Germany) with a 100 W mercury arc lamp as the light source.
dAfter 3 hr of UV exposure, the 180 min image was taken, and the
eexperiment was terminated. After the end of the experiment, the
365-nm bandpass filter was removed and replaced with a 510-nm
bandpass filter. The fiber optic shutter was left open, and an image R
was acquired in order to visualize the region exposed by UV during R
the experiment. Greater than 90% of the cell was exposed for all A
neurons in the “uncaged” and “exposed” conditions. GFP fluores- P
cence was quantified by measuring the mean pixel intensity along
the length of the dendrite and with F/F, a normalized difference Rscore, as the measure. For F/F graphs, five-point adjacent aver-
aging was used for smoothing the plots. For comparison of condi-
tions, a one-way ANOVA was performed with the LSD post-hoc test
(α = 0.05).
Local Inhibition Experiments in HEK293 Cells
HEK293 cells were maintained and propagated under standard
conditions (5% CO2 in DMEM medium containing 10% fetal bovine
serum, 10 units/ml penicillin, and 10 g/ml streptomycin). Prior to
transfection, cells were grown on poly-L-lysine-coated cell-culture
dishes (MatTek). Cells were transfected by utilizing Lipofectamine
2000 (Invitrogen, Carlsbad, CA) with a GFP reporter plasmid
(pd1EGFP-N1 [Clontech, Palo Alto, CA]). After 8 hr of transfection,
HEK293-cell-growth media was replaced with a HEPES-buffered
solution (HBS) [40] (without glycine or picrotoxin) with 5 mM ascor-
bic acid and 80 M Bhc-Anisomycin (or DMSO control). The dish
was then imaged by confocal microscopy (see below), and a field
of cells was exposed to 365 ± 10 nm light (Oriel) for 45 ms every
11 s (0.095 Hz) for 3 hr, with a total exposure time of 44.2 s for
the entire experiment. Flash duration was controlled with a Uniblitz
shutter driver (Vincent Associates, Rochester, NY), and the UV ex-
posure was delivered through a 400-m optic fiber (Rapp Opto-
Electronic, Hamburg, Germany) with a 100 W mercury arc lamp as
the light source. Subsequent fluorescent images were taken every
hour for 3 hr at which time the experiment was terminated. After
the last image, the 365-nm bandpass filter was removed and re-laced with a 510-nm bandpass filter in order to image the exposed
rea during the experiment. The data was analyzed by fitting a
88 × 288 pixel (678 m × 400 m) ellipse over the uncaging region
s determined by the image taken with the 510-nm bandpass filter
because the fiber optic came at an angle, the exposed region at
he plane of the cells was an ellipse instead of a circle). Concentric
llipses scaled up or down by 100-m increments (for both the
ajor axes of the original ellipse) were overlaid on the original fluo-
escent images with a custom macro in ImageJ. The fluorescence
etween these ellipses was measured and compared across time
oints to measure the change in fluorescence as a measure of dis-
ance from the center of the uncaging spot. Semiellipses on the
op half of the image were analyzed separately from the semiel-
ipses on the bottom half in order to determine whether the inhibi-
ion was symmetrical on both sides of the uncaging spot. The mea-
urements on the x axis of the plots in Figure 5C range from the
op (outer) semiellipse (−400 m) to the bottom (outer) semiellipse
400 m).
onfocal Microscopy
onfocal images were acquired in 0.5-m sections; image analysis
as conducted on z-compressed image stacks, which contained
he entire neuron of interest. GFP was excited at 488 nm, and emit-
ed light was collected between 510–550 nm. Images were ac-
uired with parameters that maximized the dynamic range of pixel
ntensity for the dendritic signal. The cell-body fluorescence inten-
ity was necessarily, occasionally saturated by using these param-
ters. Analysis was performed on the major dendrite of neurons
xhibiting a pyramidal neuron-like morphology.
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